로딩 중…
지수 로딩 중…
Editas Medicine, Inc.
EDIT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.69+5.49%
2026-06-18
Price Chart
Editas Medicine, Inc.+14.47%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $263M |
| Revenue | $39M |
| Net Income | $-109M |
| Total Assets | $149M |
| Net Assets | $4M |
| Value | |
| P/B | 59.75x |
| P/S | 6.81x |
| FCF Yield | -53.57% |
| Profitability | |
| ROA | -72.96% |
| Op. Margin | -297.50% |
| Revenue Growth | -39.22% |
| Financial Health | |
| Debt Ratio | 3287.89% |
| Total Debt | $72M |
| FCF | $-141M |
| Cash | $124M |
| Current Ratio | 3.22x |
| Performance | |
| 1Y Return | 14.47% |
| 1M Return | 9.35% |
| From 52W High | -40.75% |
| 1Y MDD | -59.76% |
| Trading | |
| Volume | 3,249,419 shares |
| Trading Value | $9M |
| Per Share | |
| EPS | $-1.80 |
| BPS | $0.31 |